Greenwave Dispensary & Quantum 9
Michael is currently the Chief Executive Officer for Greenwave Dispensary and Quantum 9, Inc., Michael has performed business analysis and project management for some of the largest commercial cannabis cultivation centers in the world including a facility in Canada 315,000 sq. ft. Michael has been heavily involved in the medical marijuana industry since 2009. He started his cannabis career by founding Patients for Medical Marijuana (PFMMJ). The mission of PFMMJ is to link cannabinoid-based botanical medicines specifically targeting the cannabis plant and custom cannabinoid and terpenoid profile formulations as illness combatants and symptom alleviation treatment modalities. From there he helped Critical Mass Industries, Inc. (d.b.a. Good Meds) start cultivation and dispensing efforts in the Denver, Colorado market. As an angel investor, Michael assumed the role as business consultant resulting in the organizational growth culminating in two (2) retail dispensaries and a 90,000 square foot cultivation center. Michael has practical experience with the most tightly regulated markets in the world, the Colorado Medical Marijuana Enforcement Division. In addition, Michael has retained an executive board seat at Critical Mass Industries since 2009 and an advisory board seat at Silver State Wellness of Nevada since 2014. Michael is also a top advisory and industry expert for Vida Cannabis of Nova Scotia, Canada.
Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and an international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. In 2015, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology and the effects cannabis has on the endocannabinoid system. Michael was one of the only non-medical representatives within the team of lecture leads due to his advanced knowledge of the subject matter and work within the industry.